| Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224) |
|---|
| 01/29/2002 | US6342612 Indane aldehydes and derivatives |
| 01/29/2002 | US6342599 1,3,4-oxadiazine derivatives and their use as pesticides |
| 01/29/2002 | US6342532 Antiarthritic, hypotensive agents for urogenital and glandular disorders; calcium channels modulators |
| 01/24/2002 | WO2002006265A1 Chiral compounds iii |
| 01/24/2002 | WO2002006215A1 3-arylsulfonyl-2-hydroxy-2-methylpropanoic acid derivates |
| 01/24/2002 | WO2002006213A2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 01/24/2002 | WO2002006189A2 Aniline derivatives |
| 01/24/2002 | US20020010206 Treating cyclooxygenase-2 mediated disorders. |
| 01/23/2002 | EP1173899A1 New electrolytes and lithium ion battery using the same |
| 01/23/2002 | EP1173223A2 Conjugates as therapies for cancers and prostate diseases |
| 01/23/2002 | EP0904269B1 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors |
| 01/23/2002 | EP0833826B1 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease |
| 01/23/2002 | CN1332736A Process for synthesis of 5-(-hydroxyalkyl) benzo [1,3] dioxols |
| 01/23/2002 | CN1332165A Podophyllotoxin compound and its application in pesticide |
| 01/22/2002 | US6340704 Cell differentiation inducing amide derivatives, their production and use |
| 01/17/2002 | WO2002004407A2 7-substituted tetracycline compounds |
| 01/17/2002 | WO2002004406A2 9-substituted minocycline compounds |
| 01/17/2002 | WO2002003995A2 Treatment of male sexual dysfunction |
| 01/17/2002 | WO2001046125A3 Cd45 inhibitors |
| 01/17/2002 | US20020007064 For prevention of psychotic disorders such as schizophrenia and other central nervous system diseases |
| 01/17/2002 | US20020007060 Enzyme inhibitors; connective tissue cells; antiarthritic agents; anticarcinogenic agents |
| 01/17/2002 | US20020006635 Stereoselectively hydrolyzing an anomeric mixture of 2-benzoyloxydioxolanecarboxylate with an enzyme; separating product; replacing carboxylate by reaction with a purine or pyrimidinyl derivative |
| 01/17/2002 | US20020005505 Chiral compounds |
| 01/17/2002 | DE10033337A1 Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel Biphenylcarbonsäureamide, their preparation and their use as medicaments |
| 01/17/2002 | CA2414112A1 Treatment of male sexual dysfunction |
| 01/16/2002 | CN1331674A Sulfonamide hydroxamates |
| 01/16/2002 | CN1331078A 4-beta-amino-saccharidoid side chain-4-dehydro-4'-demethylpodoph-yllotoxin derivative with antineoplastic activity and its synthesizing process |
| 01/15/2002 | US6339087 For therapy of inflammatory or allergic diseases are selected from asthma, allergic rhinitis, hypersensitivity lung diseases, hypersensitivity pneumonitis, eosinophilic pneumonias, inflammatory bowel diseases, psoriasis, dermatitis |
| 01/10/2002 | WO2002002546A1 EPOXYCARBOXYLIC ACID AMIDES, AZIDES AND AMINO ALCOHOLS AND PROCESSES FOR PREPARATION OF α-KETO AMIDES BY USING THEM |
| 01/10/2002 | WO2002002513A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/10/2002 | WO2002002507A1 2-hydroxy-5-amino-biphenyl-derivatives and oxidative hair colouring agents containing said compounds |
| 01/10/2002 | WO2002002119A1 Fatty acid synthase inhibitors |
| 01/10/2002 | US20020004608 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 01/10/2002 | CA2414881A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/10/2002 | CA2383577A1 2-hydroxy-5-aminobiphenyl derivatives and oxidative hair dyes containing these compounds |
| 01/09/2002 | CN1330631A Amide derivatives which are useful as cell factor inhibitors |
| 01/08/2002 | US6337351 Pharmaceutical compositions and methods for use |
| 01/03/2002 | WO2002102789A1 Antimicrobial and radioprotective compounds |
| 01/03/2002 | WO2002000606A1 Biphenyl compound |
| 01/03/2002 | WO2002000590A1 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis |
| 01/03/2002 | US20020002307 Process for the selective N-formylation of N-hydroxylamines |
| 01/03/2002 | US20020002177 Endothelin receptor antagonists |
| 01/03/2002 | US20020002152 Methionine aminopeptidase type 2 inhibitors; n'-((2S,3R)-3-amino-2-hydroxy-5-(isopropylsulfanyl)pentanoyl)-3-chloro benzoyl hydrazide |
| 01/02/2002 | EP1167365A1 Method of producing sesamol formic acid ester and sesamol |
| 01/02/2002 | EP1165515A1 Pyridine-2,3-dicarboxylic acid diamides |
| 01/02/2002 | EP1165505A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 01/02/2002 | EP1165501A1 Alkenyl- and alkynyl-containing metalloprotease inhibitors |
| 01/02/2002 | EP1165496A1 Substituted aniline compounds |
| 01/02/2002 | CN1329615A Hydroboronation process |
| 01/02/2002 | CN1329607A Substituted benzopyran analogs for treatment of inflammation |
| 01/01/2002 | US6335460 Treating retroviral infections, including human immunodeficiency virus, and aids |
| 01/01/2002 | US6335408 Glass transition temperature |
| 01/01/2002 | CA2010217C Aralkylamine compounds |
| 12/27/2001 | WO2001098291A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 12/27/2001 | WO2001098248A2 Hiv integrase inhibitors |
| 12/27/2001 | WO2001028979A3 Inhibitors of neuraminidases |
| 12/27/2001 | US20010056188 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 12/27/2001 | US20010056117 Oxygen-containing heterocyclic compounds |
| 12/27/2001 | US20010056107 Cyano and carboxy derivatives of substituted styrenes are inhibitors of tumor necrosis factor alpha , nuclear factor kappa B, and phosphodiesterase and can be used to treat cachexia, endotoxic shock, inflammatory conditions etc. |
| 12/27/2001 | CA2413878A1 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 12/27/2001 | CA2412985A1 Hiv integrase inhibitors |
| 12/25/2001 | US6333428 Treatment or prevention of psychiatric disorders or neurological diseases |
| 12/25/2001 | US6333339 3-Benzylpiperidine |
| 12/25/2001 | US6333337 Potassium channel inhibitors |
| 12/20/2001 | WO2001096589A1 Lignan compounds with antiproliferative properties |
| 12/20/2001 | WO2001096494A1 Chiral additives for cholesteric displays |
| 12/20/2001 | WO2001096285A1 Beta-amino acid nitrile derivatives |
| 12/20/2001 | WO2001096283A2 Hiv integrase inhibitors |
| 12/20/2001 | WO2001087838A8 Cyclohexane derivatives and their use as therapeutic agents |
| 12/20/2001 | WO2001051456A3 Antibacterial agents |
| 12/20/2001 | US20010053857 Tricyclic and tetracyclic taxane intermediates |
| 12/20/2001 | CA2412857A1 Hiv integrase inhibitors |
| 12/19/2001 | EP1164122A1 Process for producing fluorine compound through liquid-phase fluorination |
| 12/19/2001 | EP1163195A1 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction |
| 12/19/2001 | EP0951496B1 Alkyd and aralkyd derivatives of phenolic polymers |
| 12/19/2001 | EP0754674B1 Novel carboxylic ester derivatives, process for producing the same, and insecticide or insectifuge containing the same |
| 12/19/2001 | CN1327383A Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 12/19/2001 | CN1326933A Process for preparing bromo-ortho-piperonaldehyde |
| 12/18/2001 | US6331636 Treatment of central nervous system disorders, diabetes, hypertension, impotency, appetite control |
| 12/18/2001 | US6331602 Monomer and a polymer obtained therefrom |
| 12/18/2001 | US6331544 Treating positive and negative symptoms of schizophrenia and other psychoses |
| 12/18/2001 | CA2044106C Process for preparing halogenated 1,3-dioxolanes and new products obtained |
| 12/13/2001 | WO2001094295A1 Substituted stilbenes as glucose uptake enhancers |
| 12/13/2001 | WO2001049275A3 Methods and compositions for mitigating pain using nitrate esters |
| 12/13/2001 | US20010051625 Combined effects of dopamine D4 receptor ligands and serotonin reuptake inhibitors; schizophrenia; antidepressant; anxiolytic agents; psychological disorders; panic, sleep and obsessive compulsive disorders; antiischemic agents |
| 12/13/2001 | DE10032134C1 Compositions for oxidative dyeing of keratinic fibers, especially human hair, comprise new or known 2-hydroxy-5-amino-biphenyl derivatives as developers |
| 12/13/2001 | CA2411340A1 Substituted stilbenes as glucose uptake enhancers |
| 12/12/2001 | EP1161415A2 N-cyanomethylamides as protease inhibitors |
| 12/12/2001 | EP0851850B1 Synthesis of alpha-chloro or alpha-fluoro ketones |
| 12/12/2001 | EP0810201B1 Preventive/remedy for liver disease |
| 12/12/2001 | EP0781126B1 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system |
| 12/12/2001 | CN1325838A Preparation of resoreinol derivative |
| 12/11/2001 | US6329542 Preparation of (S)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes |
| 12/11/2001 | US6329536 Reacting unsaturated nitroolefin compound with beta-dicarbonyl compound in the presence of a catalyst complex and a base, catalyst complex comprising a ligand and a metal complex |
| 12/11/2001 | US6329395 Urea derivatives for treating an eating disorder or diabetes comprising administering an effective amount of a compound of claim 1 to a mammal |
| 12/11/2001 | US6329364 Crystalline form of dihydro-2,3-benzodiazepine derivative |
| 12/11/2001 | US6329143 Providing a substrate having surface bearing multiple copies of a protective group removable on exposure to an electric field or electric current; applying electric field or current to substrate; exposing to protected monomer, repeating |
| 12/06/2001 | WO2001092263A1 Novel triazolo pyrimidine compounds |
| 12/06/2001 | DE10023711A1 Propylene carbonate purified by distillation in presence of sodium iodide, prevents pressure build-up due to carbon dioxide formation when used as solvent in electrolyte |
| 12/05/2001 | EP1159278A2 Inhibitors of aspartyl protease |